azithromycin "jubilant" 250 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - azithromycindihydrat - filmovertrukne tabletter - 250 mg
azithromycin "jubilant" 500 mg filmovertrukne tabletter
jubilant pharmaceuticals nv - azithromycindihydrat - filmovertrukne tabletter - 500 mg
darzalex
janssen-cilag international n.v. - daratumumab - multipelt myelom - monoclonal antibodies and antibody drug conjugates, antineoplastic agents - multiple myelomadarzalex is indicated: in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. i kombination med bortezomib, thalidomid og dexamethason til behandling af voksne patienter med nyligt diagnosticeret med myelomatose, der er berettiget til autolog stamcelletransplantation. i kombination med lenalidomid og dexamethason, eller bortezomib og dexamethason til behandling af voksne patienter med myelomatose, som har modtaget mindst én tidligere behandling. in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or after the last therapy (see section 5. som monoterapi til behandling af voksne patienter med recidiverende og refraktær myelomatose, hvis tidligere behandling indgår en proteasome-hæmmer og et immunmodulerende agent, og som har vist, sygdommens progression på den sidste terapi. al amyloidosisdarzalex is indicated in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic light chain (al) amyloidosis.
cipralex meltz 10 mg smeltetabletter
h. lundbeck a/s - escitalopram - smeltetabletter - 10 mg
cipralex meltz 20 mg smeltetabletter
h. lundbeck a/s - escitalopram - smeltetabletter - 20 mg
palexia 20 mg/ml oral opløsning
grünenthal gmbh - tapentadolhydrochlorid - oral opløsning - 20 mg/ml
palexia 4 mg/ml oral opløsning
grünenthal gmbh - tapentadolhydrochlorid - oral opløsning - 4 mg/ml
palexia depot 100 mg depottabletter
grünenthal gmbh - tapentadolhydrochlorid - depottabletter - 100 mg
palexia depot 150 mg depottabletter
grünenthal gmbh - tapentadolhydrochlorid - depottabletter - 150 mg
palexia depot 200 mg depottabletter
grünenthal gmbh - tapentadolhydrochlorid - depottabletter - 200 mg